Research Solutions, Inc. financial data

Symbol
RSSS on Nasdaq
Location
10624 S. Eastern Ave, Suite A 614, Henderson, NV
State of incorporation
NV
Fiscal year end
June 30
Former names
Derycz Scientific Inc (to 2/22/2013)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 78.4 % -43.1%
Debt-to-equity 211 %
Return On Equity -16.2 % -68.7%
Return On Assets -5.21 % -72%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.6M shares +10%
Common Stock, Shares, Outstanding 32.5M shares +9.75%
Entity Public Float 68.8M USD +54.4%
Common Stock, Value, Issued 32.5K USD +9.75%
Weighted Average Number of Shares Outstanding, Basic 30.3M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 33.2M shares +22.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 46.6M USD +19.3%
Operating Income (Loss) 976K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2M USD -233%
Income Tax Expense (Benefit) 130K USD +321%
Net Income (Loss) Attributable to Parent -2.13M USD -237%
Earnings Per Share, Basic 0.02 USD/shares
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.92M USD -29.9%
Accounts Receivable, after Allowance for Credit Loss, Current 6.3M USD -2.5%
Assets, Current 14.4M USD -19%
Property, Plant and Equipment, Net 71.7K USD -21.5%
Goodwill 16.3M USD +405%
Assets 41.4M USD +74.6%
Liabilities, Current 16.3M USD +9.21%
Liabilities 28.6M USD +70.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -125K USD -4.88%
Retained Earnings (Accumulated Deficit) -25.6M USD -9.06%
Stockholders' Equity Attributable to Parent 12.8M USD +85.3%
Liabilities and Equity 41.4M USD +74.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 843K USD
Net Cash Provided by (Used in) Financing Activities -16.1K USD +89.7%
Net Cash Provided by (Used in) Investing Activities -2.75M USD -814%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 32.5M shares +9.75%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 825K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.92M USD -29.9%
Deferred Tax Assets, Valuation Allowance 3.13M USD -34.5%
Deferred Tax Assets, Gross 5.52M USD +13.7%
Payments to Acquire Property, Plant, and Equipment 33.8K USD +819%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.14M USD -243%
Property, Plant and Equipment, Gross 1.01M USD +6.14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 38.5M USD +26.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 312K USD +423%
Deferred Tax Assets, Net of Valuation Allowance 3.13M USD -34.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%